{
  "docId": "019de075-f8ba-716b-8bff-efc0626fbb0b",
  "docSlug": "05c7fd4a4bf9060674ad0bb316aa9afd",
  "documentTitle": "HeartBeam | Investor Presentation Deck | 18 slides",
  "authorId": "heartbeam",
  "authorName": "HeartBeam",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 9,
  "pageCount": 18,
  "prevPage": 8,
  "nextPage": 10,
  "slideType": "traction",
  "function": "show_traction",
  "density": "dense",
  "nDataPoints": 4,
  "notes": "The slide highlights the clinical validation of HeartBeam's VECG technology.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-f8ba-716b-8bff-efc0626fbb0b/9",
  "deckHref": "/decks/019de075-f8ba-716b-8bff-efc0626fbb0b",
  "deckJsonHref": "/decks/019de075-f8ba-716b-8bff-efc0626fbb0b.json",
  "deckAnchorHref": "/decks/019de075-f8ba-716b-8bff-efc0626fbb0b#slide-9",
  "components": [
    {
      "bbox": {
        "h": 0.6,
        "w": 0.4,
        "x": 0.05,
        "y": 0.225
      },
      "kind": "chart",
      "text": "AREA UNDER THE CURVE (AUC) comparing VECG and 12 Lead ECG in Event Only vs Event + Baseline scenarios.",
      "attrs": null,
      "subkind": "bar-grouped",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "70b249ed-add6-4a2b-a535-dff3fa207910",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.8,
        "x": 0.05,
        "y": 0.91
      },
      "kind": "disclaimer",
      "text": "HeartBeam AIMiGo™ has not yet been evaluated by the FDA and is not approved for clinical use in the USA or other global geographies.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5595aab6-de75-405e-bb60-4a2ab8fe3996",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.5,
        "x": 0.46,
        "y": 0.45
      },
      "kind": "list",
      "text": "CONCLUSIONS: VECG equivalent performance to standard 12 Lead ECG. Use of a baseline for comparison significantly improves accuracy. Demonstrates potential for HeartBeam technology.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2b892d7b-7ea2-4318-b050-7410394f41e8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.5,
        "x": 0.46,
        "y": 0.24
      },
      "kind": "list",
      "text": "STUDY DESIGN: 186 recordings in 66 patients undergoing percutaneous coronary intervention, causing coronary artery occlusion. VECG and 12 Lead ECG assessed on ability to detect occlusion.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f3c4b088-5c24-454a-a9bc-89d31fb5c7b0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.8,
        "x": 0.06,
        "y": 0.07
      },
      "kind": "title",
      "text": "Foundational Study Demonstrates Excellent Performance of VECG in Coronary Occlusion Detection",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "87cad937-af31-4f89-8223-ce09966a0d07",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 9,
      "from": 7,
      "beatId": "52093dbd-9cbb-41d3-88c6-355d84f1cbb5",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Solution",
      "beatSlug": "problem-agitate-solution-solution-provide-relief",
      "evidence": "The document presents the solution and its advantages (p7-9).",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [
    {
      "to": 9,
      "from": 7,
      "name": "Golden Circle",
      "slug": "11-golden-circle",
      "bestFor": "Visionary leadership, brand positioning, mission statements",
      "matchId": "f8318caa-e9d6-4114-b28b-e50a467af6c8",
      "evidence": "The document presents the solution and its advantages (p7-9), answering the why, what, and how questions.",
      "position": 1,
      "objective": "Why is HeartBeam's solution necessary?",
      "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
      "confidence": 0.6,
      "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}